Not logged inReal-World Effectiveness, Safety, and Dose Modifications of Upadacitinib in Patients with Crohn's Disease: A Canadian Multicenter Study
van Lierop, L.; Dang, R.; Omeltchenko, T.; Adriaanse, M.; Gozdzik, M.; Kroeker, K.; Halloran, B.; Wong, K.; Peerani, F.; Chow, J.; Mccurdy, J.; Narula, N.; Siffledeen, J. S.; Du, L.; Dang, T.; Ma, C.; Hoentjen, F. .png)
Share.png)
SavePrevalence and epidemiological features of adult upper gastrointestinal Crohn's disease over the last 30 years: A scoping reviewLupas, D.; Natt, N.; Elzaanoun, R.; Yuan, Y.; Mortuza, R.; Ma, C.; Vuyyuru, S.; Narula, N.; Crowley, E.; Singh, S.; Jairath, V; Sedano, R. Share Save Psychometric validation of the revised Symptoms and Impacts Questionnaire for Crohn's Disease (SIQ-CD) and Ulcerative Colitis (SIQ-UC)Hupe, M.; Narula, N.; Silverberg, M.; Bressler, B.; Ma, C.; Parkes, G.; Radford, S.; Battat, R.; Green, D.; Afif, W.; Remillard, J.; Kitchen, H.; Al-Zubeidi, T.; Collins, E.; Burns, D.; Katsampouris, E.; Ho, K. F.; Feagan, B. G.; Jairath, V Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
